{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:45:46Z","timestamp":1766087146838,"version":"3.37.3"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T00:00:00Z","timestamp":1481932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1007\/s00280-016-3219-z","type":"journal-article","created":{"date-parts":[[2016,12,17]],"date-time":"2016-12-17T07:24:20Z","timestamp":1481959460000},"page":"215-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure"],"prefix":"10.1007","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6033-3435","authenticated-orcid":false,"given":"Kim","family":"Dao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yimin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cody J.","family":"Peer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William D.","family":"Figg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael","family":"Stadelmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Burnier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Buclin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastien","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,17]]},"reference":[{"key":"3219_CR1","unstructured":"Celgene Corporation (2016) Product information REVLIMID\u00ae (lenalidomide) capsules. \n                        http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/021880s034lbl.pdf\n                        \n                    . Accessed 28 Oct 2016"},{"issue":"12","key":"3219_CR2","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1177\/0091270007309563","volume":"47","author":"N Chen","year":"2007","unstructured":"Chen N, Lau H, Kong L, Kumar G, Zeldis JB, Knight R, Laskin OL (2007) Pharmacokinetics of lenalidomide in subjects with various degrees of renal impairment and in subjects on hemodialysis. J Clin Pharmacol 47(12):1466\u20131475. doi:\n                        10.1177\/0091270007309563","journal-title":"J Clin Pharmacol"},{"issue":"2","key":"3219_CR3","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jchromb.2004.08.022","volume":"811","author":"TM Tohnya","year":"2004","unstructured":"Tohnya TM, Hwang K, Lepper ER, Fine HA, Dahut WL, Venitz J, Sparreboom A, Figg WD (2004) Determination of CC-5013, an analogue of thalidomide, in human plasma by liquid chromatography-mass spectrometry. J Chromatogr B Anal Technol Biomed Life Sci 811(2):135\u2013141. doi:\n                        10.1016\/j.jchromb.2004.08.022","journal-title":"J Chromatogr B Anal Technol Biomed Life Sci"},{"key":"3219_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1756-8722-6-41","volume":"6","author":"J Hou","year":"2013","unstructured":"Hou J, Du X, Jin J, Cai Z, Chen F, Zhou DB, Yu L, Ke X, Li X, Wu D, Meng F, Ai H, Zhang J, Wortman-Vayn H, Chen N, Mei J, Wang J (2013) A multicenter, open-label, phase 2 study of lenalidomide plus low-dose dexamethasone in Chinese patients with relapsed\/refractory multiple myeloma: the MM-021 trial. J Hematol Oncol 6:41. doi:\n                        10.1186\/1756-8722-6-41","journal-title":"J Hematol Oncol"},{"issue":"3","key":"3219_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00280-011-1760-3","volume":"69","author":"N Chen","year":"2012","unstructured":"Chen N, Wen L, Lau H, Surapaneni S, Kumar G (2012) Pharmacokinetics, metabolism and excretion of [(14)C]-lenalidomide following oral administration in healthy male subjects. Cancer Chemother Pharmacol 69(3):789\u2013797. doi:\n                        10.1007\/s00280-011-1760-3","journal-title":"Cancer Chemother Pharmacol"},{"issue":"10","key":"3219_CR6","doi-asserted-by":"publisher","first-page":"3823","DOI":"10.1093\/ndt\/gfr773","volume":"27","author":"CA Hutchison","year":"2012","unstructured":"Hutchison CA, Heyne N, Airia P, Schindler R, Zickler D, Cook M, Cockwell P, Grima D (2012) Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis. Nephrol Dial Transplant 27(10):3823\u20133828. doi:\n                        10.1093\/ndt\/gfr773","journal-title":"Nephrol Dial Transplant"},{"issue":"10","key":"3219_CR7","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1111\/aor.12248","volume":"38","author":"DH Krieter","year":"2014","unstructured":"Krieter DH, Devine E, Wanner C, Storr M, Krause B, Lemke HD (2014) Clearance of drugs for multiple myeloma therapy during in vitro high-cutoff hemodialysis. Artif Organs 38(10):888\u2013893. doi:\n                        10.1111\/aor.12248","journal-title":"Artif Organs"},{"issue":"16","key":"3219_CR8","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/cncr.25139","volume":"116","author":"M Dimopoulos","year":"2010","unstructured":"Dimopoulos M, Alegre A, Stadtmauer EA, Goldschmidt H, Zonder JA, de Castro CM, Masliak Z, Reece D, Olesnyckyj M, Yu Z, Weber DM (2010) The efficacy and safety of lenalidomide plus dexamethasone in relapsed and\/or refractory multiple myeloma patients with impaired renal function. Cancer 116(16):3807\u20133814. doi:\n                        10.1002\/cncr.25139","journal-title":"Cancer"},{"issue":"6","key":"3219_CR9","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/bjh.12708","volume":"164","author":"AK Gandhi","year":"2014","unstructured":"Gandhi AK, Kang J, Havens CG, Conklin T, Ning Y, Wu L, Ito T, Ando H, Waldman MF, Thakurta A, Klippel A, Handa H, Daniel TO, Schafer PH, Chopra R (2014) Immunomodulatory agents lenalidomide and pomalidomide co-stimulate T cells by inducing degradation of T cell repressors Ikaros and Aiolos via modulation of the E3 ubiquitin ligase complex CRL4 (CRBN). Br J Haematol 164(6):811\u2013821. doi:\n                        10.1111\/bjh.12708","journal-title":"Br J Haematol"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-016-3219-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-016-3219-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T06:12:21Z","timestamp":1484028741000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-016-3219-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,17]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["3219"],"URL":"https:\/\/doi.org\/10.1007\/s00280-016-3219-z","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"type":"print","value":"0344-5704"},{"type":"electronic","value":"1432-0843"}],"subject":[],"published":{"date-parts":[[2016,12,17]]}}}